In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
A researcher working in an MSK lab
MSK Research Highlights, September 4, 2025

New MSK research shows the Make-an-IMPACT program improves global access to genomic testing in pediatric cancer patients; helped develop an experimental antibody that shows promise against metastatic cancer; sheds light on the origins of ERG-driven prostate cancer; and finds Dupilumab is a successful agent to treat skin toxicities related to antibody-drug conjugates.
Doctors Nancy Lee, Alan Ho, and Richard Wong are seen discussing a medical image.
New Throat Cancer Treatments Aim To Reduce Deaths and Preserve Function in 2025 and Beyond

Learn how MSK's world-class Head and Neck cancer specialists help people facing throat cancer, using the latest therapies and innovations.
A hand holds a multichannel pipette above a well plate
Gerstner Sloan Kettering Graduate Students Receive 2025-2026 Fellowships

A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.
Micrograph of stained AML cells
New Type of CAR T Cells Successfully Target AML in Pilot Study

The first-ever clinical trial at MSK to evaluate a novel CAR T cell therapy for AML is showing promise.
Magnified image of cells against a dark background, with primarily cilia highlighted in red
Cell’s ‘Antenna’ Could Be Key To Curing Diseases

Learn how developmental biologists at MSK solved a decades-old cellular mystery. Their findings will have an immediate and lasting impact on the understanding and treatment of ciliopathies, which cause a host of medical problems and affect 1 in 2,000 people worldwide.
Zhi “Zack” Zheng
2025 GSK Chairman’s Prize Recognizes Research on DNA Double-Strand Breaks

This year's GSK Chairman’s Prize was awarded to Zhi “Zack” Zheng for his research on the SPO11 protein, which creates double-strand breaks in DNA.
Dr. Robin Mendelsohn
Is Shield a Good Colorectal Cancer Screening Blood Test? Hear From an MSK Expert 

MSK experts say the Shield blood test is not the best way to detect colorectal cancer and instead recommend colonoscopy or a stool test for those who can’t have a colonoscopy.
MSK breast medical oncologist Sherry Shen, MD, facing the camera and talking to a patient.
Controlling Weight Gain During Breast Cancer, Including New Research Into Ozempic and Related Weight-Loss Drugs

Learn how to control weight gain during and after breast cancer treatment, from experts at MSK.
Memorial Sloan Kettering medical oncologist Eileen O'Reilly
Vaccine Targeting KRAS in Pancreatic and Colorectal Cancer Shows Promise

Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.
An MSK researcher points to a scientific image on a screen
MSK Research Highlights, August 8, 2025

New MSK research develops a powerful new resource for studying gene regulation across eukaryotes; uncovers how “jumping genes” can drive cancer growth; describes how an unexpected oxygen sensor regulates ferroptosis; establishes a technique to map chromatin architecture in 3D; creates new models for studying schizophrenia-associated defects; and finds transcription factor 19 is critical for the responses of natural killer cells to viral infection.